Investments

Co-Investment
  • logo palex bon_0.jpg
    Co-Investment

    Palex

    Spain

    Healthcare & life science
    Healthcare & life science

    Fondé en 1955, Palex est un distributeur indépendant de dispositifs médicaux d'Europe du Sud pour les hôpitaux publics et privés. Avec un large portefeuille de produits et des partenariats souvent exclusifs avec des équipementiers, Palex couvre différents domaines thérapeutiques. Palex exploite des entrepôts à travers l'Espagne, le Portugal et l'Italie.

  • healthcare-australia-logo
    Co-Investment

    Healthcare Australia

    Australia

    Healthcare & life science
    Healthcare & life science

    Founded in 1972, Healthcare Australia (“HCA”) provides healthcare staffing solutions, primarily nurses, support workers and doctors to hospitals, residential care facilities, disability support providers and government. HCA also provides direct care to the aged and disability sectors.

  • chauvet-sons-logo
    Co-Investment

    Chauvet & Sons

    USA

    Industrials
    Industrials

    Founded in 1990 by current CEO Albert Chauvet, Chauvet & Sons is a designer and asset-light manufacturer of lighting solutions for live experiences across various settings and end markets. Chauvet serves customers through its global network.

  • Ahead logo
    Co-Investment

    AHEAD

    USA

    Technology, Media and Telecom
    Technology, Media and Telecom

    Founded in 2007, AHEAD is a hybrid IT solutions Value-Added Reseller of enterprise hardware, software and services solutions for datacenters, hybrid cloud deployments and enterprise service management.

The Ardian team brought a deep sector knowledge, which I think allowed them not only to do a terrific job in that due diligence period, but also meant they could work very efficiently within our deal time frame.

Doug Brody KKR Capital Market

Ardian and Arsenal both want our investments to benefit society and by working together in this case we’ve reduced the time it takes to set up a clinical trial by many months, which means new drugs come to market as quickly and safely as possible.

Steve McLean Partner of Arsenal Capital

During the due diligence phase, we identified Ardian as a future shareholder capable of making a significant contribution to Emera's development. As soon as the transaction closed, we were able to define and launch value-creating initiatives with Naxicap and Ardian, particularly in terms of group structuring, external growth, digital transformation and real estate strategy, in France but also in Spain and other European countries.

Eric Baugas CEO of EMERA